Paul Daugherty

As Thomas Kawalec mentioned, technology is no longer a "nice to have" - it's essential for building a strong, adaptable MedTech company. Accenture is committed to continuous improvement, and we are tackling this with tech-powered visibility & predictability, shift-left engineering, and digital workforce development for our clients. P.S. Dive deeper into these strategies in our latest blog post: https://lnkd.in/dj227sYn

64

Explore Deloitte’s report (authored by 3 of my esteemed colleagues) to learn how 3 #CellAndGene therapy pricing models could help transform how CGT therapies are financed. https://deloi.tt/3RE72Lm

10

Will technology create seamless experiences for patients, providers, and payers? @Dan Galdenzi, head of EY Nexus for Health, is leading the charge. Discover their groundbreaking work in healthcare interoperability, data sharing, and more. Tune in to hear Dan's insights with Sandy Vance. Listen here: ow.ly/CeHT50RGMmx #interoperability #digitalhealth #healthit

10

1 Comment

It is interesting to see how AI leadership takes shape in the healthcare industry. We're seeing organizations hire Chief AI Officers, while others have the CIO, data or digital leaders overseeing AI implementation. We're monitoring these trends. Here's our latest observations. https://lnkd.in/gX3yrDH9  

11

1 Comment

I am proud to share that we at Deloitte, along with Moffitt Cancer Center, NVIDIA, and Oracle, are taking a significant stride into the future of cancer care. How? By integrating #AI and machine learning into the heart of clinical operations. This isn't just about technology, it's about real people. It's about optimizing care, enhancing outcomes, and most of all - making a difference for patients. Read more here - https://deloi.tt/3Ux4aln I'm also eager to hear your insights on this revolutionary journey we're commencing. How do you envision AI redefining healthcare in the future? Nitin Mittal Peter Micca #AIinHealthcare #TransformingCancerCare

92

3 Comments

GenAI’s potential in #healthcare extends across diagnostics, patient care, and beyond. Imagine AI-powered tools that streamline patient interactions, refine diagnosis, and optimize treatments—all while lowering costs. The tech is reshaping the value of care and patient outcomes in real time. Learn more: https://on.bcg.com/3Z6ymX7

11

1 Comment

As AI continues to shape the future of business, it's crucial for boards to understand the risks and opportunities involved. In a Q&A with Corporate Board Member, Diligent's President and CEO Brian Stafford discusses best practices for how boards should be approaching AI adoption.

1

BCG and Massachusetts High Technology Council–in collaboration with leaders from industry, hospitals, and academia–examine AI’s transformative potential in patient care and life sciences in a recent white paper. Read to learn how we plan to lead in applied #AI, focusing on better patient outcomes and groundbreaking innovations: https://on.bcg.com/3xqah2s

18

1 Comment

#AI is disrupting M&A #careers: from reducing Associates workloads to enhance Senior Executive's strategic decision making. Will this lead to: better life-work balance? Higher profitability? Or, will just customers become more demanding for all sizes of deals? Check out our blogpost here 👉 https://lnkd.in/eap4gt84

13

As AI continues to shape the future of business, it's crucial for boards to understand the risks and opportunities involved. In a Q&A with Corporate Board Member, Diligent's President and CEO Brian Stafford discusses best practices for how boards should be approaching AI adoption.

3

In this timely piece, KPMG US Joe Zaccaria and Lindsey Manning explore the rising importance of real-world data (RWD) in healthcare and life sciences organizations. Early adopters are addressing the emergence of Generative AI models, complex clinical development programs, the shift toward value-based delivery, and FDA guidance to foster innovation, establish industry partnerships, and enhance patient-centered care. #RealWorldData #KPMGLifeSciences #HealthcareInnovation #GenAI #KPMGDeals https://bit.ly/4cQaF9D

4

In this timely piece, KPMG US Joe Zaccaria and Lindsey Manning explore the rising importance of real-world data (RWD) in healthcare and life sciences organizations. Early adopters are addressing the emergence of Generative AI models, complex clinical development programs, the shift toward value-based delivery, and FDA guidance to foster innovation, establish industry partnerships, and enhance patient-centered care. #RealWorldData #KPMGLifeSciences #HealthcareInnovation #GenAI #KPMGDeals https://bit.ly/3ZMx8Ry

2

Check out our partnership with Microsoft, highlighting how we help clients unlock data potential, drive efficiency, and empower teams with AI Copilots and Agents. Don’t miss our session: 5 trends driving transformation in healthcare and life sciences: https://bit.ly/48IslTl

2

For those heading to #MSIgnite be sure to check out Meagan’s session on driving tangible value with AI!

8

#GenerativeAI is accelerating organizational performance faster than any previous tech cycle. Accenture’s Jack Azagury calls it 'the fastest-growing technology we’ve ever seen,' but success requires more than just #AI. A strong #DigitalCore and a strategic talent approach are key to unlocking its full potential. Explore how organizations are embracing this AI-driven reinvention in this Forbes article. https://accntu.re/4dsZJ1d

2